Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 29, 2022 at 10:51 am EDT
Share
Chempartner Pharmatech Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 386.3 million compared to CNY 389.71 million a year ago. Revenue was CNY 386.3 million compared to CNY 389.71 million a year ago. Net income was CNY 9.47 million compared to CNY 1.63 million a year ago. Basic earnings per share from continuing operations was CNY 0.019 compared to CNY 0.0033 a year ago. Diluted earnings per share from continuing operations was CNY 0.019 compared to CNY 0.0033 a year ago.
ChemPartner PharmaTech Co Ltd, formerly Quantum Hi-tech China Biological Co Ltd, is a China-based company principally engaged in the research, development, production, and sales of fructooligosaccharides and other prebiotics. The Company's main products include fructooligosaccharides and galactooligosaccharides. The Company owns brands names of FOS and GOS. The Company's products are mainly used in nutrition and health products, dairy products, beverages, baked goods, functional candy and snack foods. The Company distributes its products mainly in domestic market, with South China as its main market.
CHEMPARTNER PHARMATECH CO., LTD. 
